{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:06:00Z","timestamp":1761919560621},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:00:00Z","timestamp":1337817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037432","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T22:06:30Z","timestamp":1337897190000},"page":"e37432","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer"],"prefix":"10.1371","volume":"7","author":[{"given":"Felipe","family":"Vaca-Paniagua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Mar\u00eda","family":"Alvarez-Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Fragoso-Ontiveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Vidal-Millan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Alonso","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cant\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Bargallo-Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Mohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar","family":"L\u00f3pez-Camarillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"P\u00e9rez-Plasencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,24]]},"reference":[{"key":"ref1","first-page":"323","article-title":"Hereditary Breast and Ovarian Cancer: New Genes, New Treatments, New Concepts.","volume":"108","author":"A Meindl","year":"2011","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and beyond.","volume":"4","author":"SA Narod","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2.","volume":"12","author":"N Petrucelli","year":"2010","journal-title":"Genetics in Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"F Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2004.01.032","article-title":"BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.","volume":"158","author":"HT Lynch","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/345310","article-title":"Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.","volume":"72","author":"SM Edwards","year":"2003","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/mcp.2010.0414","article-title":"Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer.","volume":"85","author":"S Pruthi","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"i31","DOI":"10.1093\/annonc\/mdq663","article-title":"Hereditary breast cancer: clinical features and risk reduction strategies.","volume":"22","author":"A Paradiso","year":"2011","journal-title":"Annals of Oncology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10911-011-9200-x","article-title":"Clinical management of hereditary breast cancer syndromes.","volume":"16","author":"AS Clark","year":"2011","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ejhg.5201806","article-title":"Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review.","volume":"15","author":"A Gerhardus","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/GIM.0b013e31822a8113","article-title":"Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.","volume":"13","author":"G Wang","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/humu.21428","article-title":"Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations.","volume":"32","author":"K De Leeneer","year":"2011","journal-title":"Hum Mutat"},{"key":"ref13","first-page":"527","article-title":"Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients.","volume":"30","author":"S Vidal-Mill\u00e1n","year":"2009","journal-title":"European journal of gynaecological oncology"},{"issue":"10","key":"ref14","first-page":"1052","article-title":"Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet.","volume":"19","author":"J Th\u00e9ry","year":"2011"},{"key":"ref15","first-page":"1811","article-title":"Inherited breast and ovarian cancer.","author":"CI Szabo","year":"1995"},{"key":"ref16","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.","volume":"56","author":"DF Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance.","volume":"25","author":"S Chen","year":"2007","journal-title":"Journal of Clinical Oncology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2008.21.4684","article-title":"Preventing future cancers by testing women with ovarian cancer for BRCA mutations.","volume":"28","author":"JS Kwon","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"ref19","first-page":"708","article-title":"The role of BRCA mutation testing in determining breast cancer therapy.","volume":"7","author":"AH Trainer","year":"2010","journal-title":"Nature Publishing Group"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(10)60892-6","article-title":"Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.","volume":"376","author":"A Tutt","year":"2010","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"vi93","DOI":"10.1093\/annonc\/mdm234","article-title":"Founder mutations in BRCA1 and BRCA2 genes.","volume":"18","author":"R Ferla","year":"2007","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2353\/jmoldx.2009.080137","article-title":"A rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencing.","volume":"11","author":"L Zhang","year":"2009","journal-title":"J Mol Diagn"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/humu.9084","article-title":"BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico.","volume":"20","author":"P Ruiz-Flores","year":"2002","journal-title":"Hum Mutat"},{"key":"ref24","article-title":"BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica.","author":"G Guti\u00e9rrez Espeleta","year":"2011"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/bcr3049","article-title":"Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness.","volume":"13","author":"EH Lips","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.breast.2006.12.003","article-title":"BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.","volume":"16","author":"A Musolino","year":"2007","journal-title":"Breast"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ijc.11271","article-title":"Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.","volume":"106","author":"S de Sanjos\u00e9","year":"2003","journal-title":"Int J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2007.04.023","article-title":"Genetic epidemiology of BRCA mutations-family history detects less than 50% of the mutation carriers.","volume":"43","author":"P M\u00f8ller","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.","volume":"68","author":"D Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10549-011-1655-3","article-title":"Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1\/2 carrier cohort (GENEPSO).","volume":"130","author":"J Lecarpentier","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10549-009-0394-1","article-title":"Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.","volume":"119","author":"RL Milne","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10549-006-9161-8","article-title":"Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.","volume":"98","author":"A Nkondjock","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2164-12-245","article-title":"Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing.","volume":"12","author":"A Gilles","year":"2011","journal-title":"BMC Genomics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.9154","article-title":"Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.","volume":"22","author":"W Hofmann","year":"2003","journal-title":"Hum Mutat"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/hmg\/ddg120","article-title":"Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast\/ovarian cancer families.","volume":"12","author":"M Montagna","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1590\/S1415-47572009005000049","article-title":"Genomic rearrangements in BRCA1 and BRCA2: A literature review.","volume":"32","author":"IP Ewald","year":"2009","journal-title":"Genet Mol Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2353\/jmoldx.2009.090032","article-title":"Genotyping of frequent BRCA1\/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden.","volume":"11","author":"K De Leeneer","year":"2009","journal-title":"J Mol Diagn"},{"key":"ref38","article-title":"Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.","author":"A Blanco","year":"2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-011-1548-5","article-title":"Two new CHEK2 germ-line variants detected in breast cancer\/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations.","volume":"130","author":"S Manoukian","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.","volume":"42","author":"A Meindl","year":"2010","journal-title":"Nat Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10549-011-1677-x","article-title":"Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.","volume":"130","author":"M Vuorela","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/83762","article-title":"A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.","volume":"27","author":"HX Liu","year":"2001","journal-title":"Nat Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-06-3297","article-title":"Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.","volume":"67","author":"MA Carvalho","year":"2007","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ejhg.2008.13","article-title":"Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.","volume":"16","author":"M Tischkowitz","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","article-title":"Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure.","volume":"314","author":"AG Nackley","year":"2006","journal-title":"Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/hmg\/ddg055","article-title":"Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.","volume":"12","author":"J Duan","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/342506","article-title":"Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.","volume":"71","author":"A Liede","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1136\/jmg.2003.012104","article-title":"Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast\/ovarian families.","volume":"41","author":"DGR Evans","year":"2004","journal-title":"Journal of Medical Genetics"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2350-7-75","article-title":"Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.","volume":"7","author":"S Saxena","year":"2006","journal-title":"BMC Med Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canlet.2005.03.006","article-title":"BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain.","volume":"233","author":"R Salazar","year":"2006","journal-title":"Cancer Letters"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmg.2006.044388","article-title":"Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.","volume":"44","author":"J Simard","year":"2007","journal-title":"Journal of Medical Genetics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"E1200","DOI":"10.1002\/humu.21202","article-title":"Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.","volume":"31","author":"A Borg","year":"2010","journal-title":"Hum Mutat"},{"key":"ref53","first-page":"623","article-title":"[Characterization of the BRCA1 gene and its significance in hereditary breast cancer].","volume":"107","author":"O D\u00edez Gilbert","year":"1996","journal-title":"Med Clin (Barc)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T02:10:43Z","timestamp":1540260643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037432"}},"subtitle":[],"editor":[{"given":"Sandra","family":"Orsulic","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037432","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}